# Case Report: Giant cystic solid aggressive fibromatosis of the pancreas: clinical and pathologic features

**Authors:** Runlin Feng, Tao Zhang, Lijuan Feng, Yanping Tao, Jiaping Wang

PMC · DOI: 10.3389/fonc.2025.1634715 · Frontiers in Oncology · 2025-10-08

## TL;DR

This case report describes a rare instance of aggressive fibromatosis in the pancreas, highlighting its diagnosis and treatment.

## Contribution

The novelty lies in the rare occurrence of primary pancreatic aggressive fibromatosis and its successful surgical treatment with no recurrence.

## Key findings

- Aggressive fibromatosis originating from the pancreatic region is extremely rare.
- Definitive diagnosis relies on postoperative pathology and immunohistochemistry.
- Complete surgical resection is the treatment of choice with successful outcomes observed.

## Abstract

Aggressive fibromatosis is a rare and aggressive soft tissue tumor. The pathologic histomorphology is varied and characterized by fibroblast and myofibroblast differentiation. Aggressive fibromatosis can be classified into extra-abdominal, abdominal wall, and intra-abdominal types. The abdominal wall type is the most common, while originating from the pancreatic region is extremely rare. Therefore, we report a case of a patient with a diagnosis of giant cystic solid aggressive fibromatosis of the pancreas.

The patient was a 39-year-old woman who was admitted to the hospital because of left upper abdominal pain that persisted for 20 days. She was in relatively good health with no history of previous illnesses. No additional abnormal manifestations were noted on physical examination. Laparoscopic pancreatic body and tail combined splenectomy was performed under general anesthesia. The postoperative pathologic diagnosis was pancreatic aggressive fibroma. No disease recurrence was observed during the postoperative follow-up period.

The primary pancreatic aggressive fibroma is very rare. The clinical presentation lacks specificity, and imaging findings are not quite typical. The definitive diagnosis relies on postoperative pathology and immunohistochemistry. Complete surgical resection is the treatment of choice when possible. Due to its aggressive behavior, regular follow-up is required.

## Linked entities

- **Diseases:** aggressive fibromatosis (MONDO:0007608)

## Full-text entities

- **Diseases:** Aggressive fibromatosis (MESH:D018222), aggressive (MESH:D010554), fibromatosis of the pancreas (MESH:D005350), soft tissue tumor (MESH:D012983), pancreatic aggressive fibroma (MESH:D010195), abdominal pain (MESH:D015746)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12540156/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12540156/full.md

## References

21 references — full list in the complete paper: https://tomesphere.com/paper/PMC12540156/full.md

---
Source: https://tomesphere.com/paper/PMC12540156